No info available.

• Best Dissertation: Research mentoring Award - College of Sciences, UTEP (12/01/2014-12/31/2014)
• UTEP-ORSP Oustanding Performance Award - UTEP-ORSP (05/01/2013-05/31/2013)
• BRFSS (Behavioral Risk Factor Surveillance Survey) Award - Paso del Norte Health Foundation (PdNHF) and the Center for Border Health Research (CBHR) (01/01/2008-01/31/2008)
• BRFSS (Behavioral Risk Factor Surveillance Survey) Award - Paso del Norte Health Foundation (PdNHF) (12/01/2005-12/31/2005)
• UTEP ADVANCE Initiative Award - “Molecular identification of tumor-associated antigens as markers in hepatocellular carcinoma” (01/01/2005-01/31/2005)
• The Second Award from Jiangxi Province Scientific Commission, P. R. CHINA. - Study of Circulating Immune Complexes with IgG / Complement Specificity. (01/01/1996-12/31/1996)
• The Third Award from Henan Province Educational Commission , P. R. CHINA. - Book: Research and Practice In Liver Diseases. (01/01/1996-12/31/1996)
• The Third Award from Henan Province Health Bureau, - A Seroepidemiological Study of Hepatitis D Virus (HDV) Infection in Henan, (01/01/1996-12/31/1996)
• The Second Award from Henan Province Health Bureau - A Study of Efficacy Evaluation and Re-Vaccination of Hepatitis B Vaccine. (01/01/1995-12/31/1995)
• The Third Award from Henan - Book: Research Advance In Viral Liver Diseases. (01/01/1995-12/31/1995)
• A Study of Protective Value of Isolated Anti-HBs Positivity in Human Sera. - Henan Province Health Bureau & The Second Award from Henan Province Scientific Commission, P. R. CHINA. (01/01/1994-12/31/1994)
• Excellent Young Scientist Award from Henan Province Government - Henan Province Government, P. R. CHINA (01/01/1994-12/31/1994)
• Excellent Youth Teacher Award of Henan Province, P. R. CHINA. - Henan Province, P. R. CHINA (01/01/1993-12/31/1993)
• Therapeutic Study of Hepatitis B by Using Chinese Medicinal herbs. - Henan Province Scientific Commission, P. R. CHINA. (01/01/1993-12/31/1993)
• Epidemiology Teaching Research Program. - Henan Medical University, P. R. CHINA. (01/01/1992-12/31/1992)

• Cancer Autoimmunity, The Scripps Research Institute (2001)
• Ph D in Tumor Molecular Biology and Tumor Immunology, Xia'men University (1995)
• MPH in Epidemiology, Xi'an Jiaotong University School of Medicine (Former Xi'an Medical University) (1987)
• MD in Medicine, Zhengzhou University School of medicine (Former Henan Medical University) (1984)

• A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations. Cancers 15 16 (2023), C Qiu, X Wang, SA Batson, CA Casiano, Giulio Francia, Jianying Zhang.
• Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. International Journal of Molecular Sciences 24 4 (2023), C Qiu, Y Ma, B Wang, X Zhang, X Wang, Jianying Zhang.
• Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1 Molecules 28 2 (2023), X Zhang, M Xing, Y Ma, C Qiu, X Wang, Jianying Zhang.
• Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells 11 20 (2022), Yangcheng Ma, Cuipeng Qiu, Xiaojun Zhang, Xiao Wang, Renato J. Aguilera, Jianying Zhang.
• Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells 11 20 (2022), Y Ma, C Qiu, B Wang, X Zhang, X Wang, Renato Aguilera, Jianying Zhang.
• Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilization. Frontier in Oncology 12 (2022), Jianying Zhang.
• Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC Patients Biomedicines 10 1 (2022), X Wang, C Qiu, B Wang, X Zhang, Y Ma, Jianying Zhang.
• Immunoseroproteomic profifiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach Oncoimmunology (2021), J Li, Jianying Zhang.
• Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International journal of molecular sciences 22 11 (2021), M Xing, R A. Kirken, L He, Jianying Zhang.
• Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers. Scientific reports 11 1 (2021), L Cambier, K Stachelek, M Triska, R Jubran, M Huang, W Li , Jianying Zhang, J Li , D Cobrinik.
• Knockdown of Kremen2 Inhibits Tumor Growth and Migration in Gastric Cancer Frontiers in Oncology, section Gastrointestinal Cancers. (2021), B Chen, j Li, Jianying Zhang.
• Overexpression of p62/IMP2 can promote cell migration in hepatocellular carcinoma via activating Wnt/β-catenin pathway. Cancers 12 1 (2020), Mengtao Xing, Xiao Wang, Jitian Li, Xiaojun Zhang, Yangcheng Ma, Giulio Francia, Jianying Zhang.
• Overexpression of p62/IMP2 can Promote Cell Migration in Hepatocellular Carcinoma via Activation of the Wnt/ β-Catenin Pathway Cancers (Basel). 2019 Dec 18;12(1):7. doi: 10.3390/cancers12010007. (2019), Mengtao Xing, Giulio Francia, Jianying Zhang.
• Key indexes and the emerging tool for tumor microenvironment editing. American journal of cancer research 9 5 (2019), X Dai, Y Luo, Y Xu, Jianying Zhang.

• A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer. (2024), Volume UTEP, C Qiu, X Wang, SA Batson, CA Casiano, Giulio Francia, Jianying Zhang.
• Exploring autoantibody response to proteins encoded by prostate cancer driver genes. (2023), Volume Toronto, Canada, C Qiu, X Wang, Najera SB Garcia, Jianying Zhang.
• Using Luminex approach to develop a panel of anti-TAA autoantibodies for the detection of prostate cancer. (2023), Volume Orlando, FL, C Qiu, X Wang, SA Batson, CA Casiano, Giulio Francia, Jianying Zhang.
• The significance of autoantibodies to tumor-associated antigens (TAAs) as biomarkers in pancreatic cancer. (2022), Volume Maui, Hawaii, X Wang, C Qiu, Garcia Najera SB, Jianying Zhang.
• Autoantibodies to PAX5, PTCH1, and GNA11 as serological biomarkers in the detection of hepatocellular carcinoma in Hispanic Americans. (2022), Volume New Orleans, Louisiana, Cuipeng Qiu, Xiao Wang, Baofei Wang, Yangcheng Ma, Xiaojun Zhang, Jianying Zhang.
• Using proteomic approach to identify potential tumor-associated antigens (TAAs) as biomarkers in Hispanic hepatocellular carcinoma. (2022), Volume New Orleans, Louisiana, Yangcheng Ma, Cuipeng Qiu, Xiaojun Zhang, Jianying Zhang.
• Anti-GNAS autoantibody as a biomarker in liver cancer (2021), Volume Virtual Conference, X Wang, Y Ma, C Qiu, X Zhang, M Xing, A Varela, Jianying Zhang.
• Metformin is able to regulate tumor progression of Hepatocellular Carcinoma cells via p90/CIP2A in vitro (2020), Volume San Diego, CA, Yangcheng Ma, Jianying Zhang.
• Oridonin inhibits cell growth of esophageal carcinoma cells via induction of apoptosis (2020), Volume San Diego, CA, Xiaojun Zhang, Jianying Zhang.
• Identifying the role of p62/IMP2 in the progression of breast cancer. (2019), Volume UTEP, Zenaida Fuentes, Mengtao Xing, Jianying Zhang.
• Overexpression of p62/IMP2 can promote cell migration in hepatocellular carcinoma (HCC) via activating Wnt/β-catenin pathway. (2019), Volume Atlanta, Georgia, Mengtao Xing, Giulio Francia, Jianying Zhang.
• Overexpression of p62/IMP2 can promote cell migration in hepatocellular carcinoma (HCC) via activating Wnt/β-catenin pathway. (2019), Volume Atlanta, Georgia, Mengtao Xing, Giulio Francia, Jianying Zhang.
• Hallmark of immune responses to multiple tumor-associated antigens in immunodiagnosis of liver cancer and other solid tumors (2019), Volume Loma Linda, CA, Jianying Zhang.

• Investigation of the microbiota of colon cancer precursors in Hispanics at the border region
• U54 BBRC Grant-Project 2 (Clinical Project): Developing Diagnostic and Therapeutic Strategies to Reduce Hispanic Cancer Disparities Using Genetic, Molecular and Physiological Signatures from Mexican origin Cancer Patients
• Intratumoral denatured tumor proteins may increase tumor-associated antigenicity for autologous tumor immunnization in vitro